These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 29512102)
1. Impact of post-dilatation on strut apposition of second-generation bioresorbable vascular scaffolds: Key role for scaffold thrombosis and prognosis? Frangieh AH; Jaguszewski M; Imori Y; Obeid S; Templin C Cardiol J; 2018; 25(1):148-150. PubMed ID: 29512102 [No Abstract] [Full Text] [Related]
2. Intraluminal bioresorbable vascular scaffold dismantling with aneurysm formation leading to very late thrombosis. Patel A; Nazif T; Stone GW; Ali ZA Catheter Cardiovasc Interv; 2017 Apr; 89(5):876-879. PubMed ID: 28145045 [TBL] [Abstract][Full Text] [Related]
4. Use of a bioresorbable novolimus eluting vascular scaffold fails a hybrid PCI strategy with drug eluting stent. Schneider VS; Skurk C; Riedel M; Abdelwahed YS; Landmesser U; Leistner DM Clin Res Cardiol; 2017 Jul; 106(7):557-559. PubMed ID: 28374059 [No Abstract] [Full Text] [Related]
5. Bioresorbable vascular scaffolds: implication of very late scaffold thrombosis. Mori H; Virmani R; Finn AV Coron Artery Dis; 2017 Nov; 28(7):533-538. PubMed ID: 28692483 [No Abstract] [Full Text] [Related]
6. Restenosis of Coronary Bioresorbable Vascular Scaffolds. Alfonso F; García-Guimaraes M Rev Esp Cardiol (Engl Ed); 2017 Jul; 70(7):527-531. PubMed ID: 28285939 [No Abstract] [Full Text] [Related]
9. Late Self-Apposition With One-Year Persisting Uncoverage of Malapposed Bioresorbable Polymeric Struts. Francaviglia B; Capranzano P; Capodanno D; Barbanti M; Tamburino CI; Buccheri S; Tamburino C Can J Cardiol; 2017 Jul; 33(7):951.e5-951.e6. PubMed ID: 28579161 [No Abstract] [Full Text] [Related]
10. Very Late Thrombosis of a Bioresorbable Scaffold. Rumiz González E; Vilar Herrero JV; Berenguer Jofresa A Rev Esp Cardiol (Engl Ed); 2016 Feb; 69(2):211. PubMed ID: 26419578 [No Abstract] [Full Text] [Related]
11. Neointimal proliferation is associated with clinical restenosis 2 years after fully bioresorbable vascular scaffold implantation. Indolfi C; Mongiardo A; Spaccarotella C; Caiazzo G; Torella D; De Rosa S Circ Cardiovasc Imaging; 2014 Jul; 7(4):755-7. PubMed ID: 25027457 [No Abstract] [Full Text] [Related]
12. Bioresorbable vascular scaffolds in coronary bifurcation lesions: The next frontiers? Leesar MA Catheter Cardiovasc Interv; 2016 Nov; 88(6):870-871. PubMed ID: 27886452 [No Abstract] [Full Text] [Related]
13. Pitfalls of bioresorbable vascular scaffold thrombosis--be sure to cover it all. Abu Sharar H; Katus HA; Bekeredjian R Int J Cardiol; 2014 Dec; 177(3):1067-8. PubMed ID: 25465842 [No Abstract] [Full Text] [Related]
14. Very late bioresorbable vascular scaffold thrombosis due to late device recoil. Cortese B; Piraino D; Ielasi A; Steffenino G; Orrego PS Int J Cardiol; 2015; 189():132-3. PubMed ID: 25889443 [No Abstract] [Full Text] [Related]
15. Late neoatherosclerotic scaffold failure: An unexpected achilles heel for current bioresorbable scaffold technology? Hiltrop N; Jorge C; Bennett J; Adriaenssens T Int J Cardiol; 2016 Nov; 223():133-135. PubMed ID: 27537739 [No Abstract] [Full Text] [Related]
17. Bioresorbable Vascular Scaffold Thrombosis: Clinical and Optical Coherence Tomography Findings. Cuesta J; García-Guimaraes M; Basante T; Rivero F; Antuña P; Alfonso F Rev Esp Cardiol (Engl Ed); 2019 Jan; 72(1):90-91. PubMed ID: 29223378 [No Abstract] [Full Text] [Related]
18. Differential thrombotic prolapse burden in either bioresorbable vascular scaffolds or metallic stents implanted during acute myocardial infarction: The snowshoe effect: Insights from the maximal footprint analysis. Diletti R; van der Sijde J; Karanasos A; Fam JM; Felix C; van Mieghem NM; Regar E; Rapoza R; Zijlstra F; van Geuns RJ Int J Cardiol; 2016 Oct; 220():802-8. PubMed ID: 27394977 [TBL] [Abstract][Full Text] [Related]
19. Bioresorbable vascular scaffold thrombosis in a consecutive cohort of 550 patients. Tröbs M; Achenbach S; Röther J; Klinghammer L; Schlundt C Catheter Cardiovasc Interv; 2016 Nov; 88(6):872-880. PubMed ID: 27142643 [TBL] [Abstract][Full Text] [Related]
20. Temporal Trends in Adverse Events After Everolimus-Eluting Bioresorbable Vascular Scaffold Versus Everolimus-Eluting Metallic Stent Implantation: A Meta-Analysis of Randomized Controlled Trials. Montone RA; Niccoli G; De Marco F; Minelli S; D'Ascenzo F; Testa L; Bedogni F; Crea F Circulation; 2017 May; 135(22):2145-2154. PubMed ID: 28559495 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]